Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation.

Khodarev NN, Park J, Kataoka Y, Nodzenski E, Hellman S, Roizman B, Weichselbaum RR, Pelizzari CA.

Genomics. 2003 Feb;81(2):202-9.

PMID:
12620398
2.

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.

Gupta VK, Jaskowiak NT, Beckett MA, Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E, Pejovic M, Kufe DW, Posner MC, Weichselbaum RR.

Cancer J. 2002 Jan-Feb;8(1):47-54.

PMID:
11895203
3.

Method of RNA purification from endothelial cells for DNA array experiments.

Khodarev NN, Yu J, Nodzenski E, Murley JS, Kataoka Y, Brown CK, Grdina DJ, Weichselbaum RR.

Biotechniques. 2002 Feb;32(2):316, 318, 320. No abstract available.

4.

Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts.

Khodarev NN, Park JO, Yu J, Gupta N, Nodzenski E, Roizman B, Weichselbaum RR.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12665-70.

5.

Angiostatin effects on endothelial cells mediated by ceramide and RhoA.

Gupta N, Nodzenski E, Khodarev NN, Yu J, Khorasani L, Beckett MA, Kufe DW, Weichselbaum RR.

EMBO Rep. 2001 Jun;2(6):536-40.

6.

Angiostatin induces mitotic cell death of proliferating endothelial cells.

Hari D, Beckett MA, Sukhatme VP, Dhanabal M, Nodzenski E, Lu H, Mauceri HJ, Kufe DW, Weichselbaum RR.

Mol Cell Biol Res Commun. 2000 May;3(5):277-82.

PMID:
10964751
7.

Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis.

Chmura SJ, Nodzenski E, Kharbanda S, Pandey P, Quintans J, Kufe DW, Weichselbaum RR.

Mol Pharmacol. 2000 Apr;57(4):792-6.

PMID:
10727527
8.

Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.

Seetharam S, Nodzenski E, Beckett MA, Heimann R, Cha A, Margulies I, Pastan I, Kufe DW, Weichselbaum RR.

Cancer Res. 1998 Aug 1;58(15):3215-20.

9.

Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma.

Portugal LG, Goldenberg JD, Wenig BL, Ferrer KT, Nodzenski E, Sabnani JB, Javier C, Weichselbaum RR, Vokes EE.

Arch Otolaryngol Head Neck Surg. 1997 Nov;123(11):1230-4.

PMID:
9366703
10.

Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.

Chmura SJ, Mauceri HJ, Advani S, Heimann R, Beckett MA, Nodzenski E, Quintans J, Kufe DW, Weichselbaum RR.

Cancer Res. 1997 Oct 1;57(19):4340-7.

11.

Loss of ceramide production confers resistance to radiation-induced apoptosis.

Chmura SJ, Nodzenski E, Beckett MA, Kufe DW, Quintans J, Weichselbaum RR.

Cancer Res. 1997 Apr 1;57(7):1270-5.

12.

Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase.

Chmura SJ, Nodzenski E, Weichselbaum RR, Quintans J.

Cancer Res. 1996 Jun 15;56(12):2711-4.

13.

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.

Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, Vokes EE, Weichselbaum RR.

Clin Cancer Res. 1996 Apr;2(4):755-62.

14.

Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231.

Chmura SJ, Nodzenski E, Crane MA, Virudachalam S, Hallahan DE, Weichselbaum RR, Quintans J.

Adv Exp Med Biol. 1996;406:39-55.

PMID:
8910670
15.
16.

Deoxyadenosine- and cyclic AMP-induced cell cycle arrest and cytotoxicity.

Albert DA, Nodzenski E, Cruz GH, Kuchibholtla J, Kowalski J.

Exp Cell Res. 1991 Nov;197(1):75-81.

PMID:
1655503
18.

The dose dependent effect of cyclic AMP on ribonucleotide reductase in mitogen stimulated mononuclear cells.

Albert D, Kowalski J, Nodzenski E, Micek M, Wu P.

Biochem Biophys Res Commun. 1990 Mar 16;167(2):383-90.

PMID:
2157402
19.

Cell cycle regulation of ribonucleotide reductase M2 subunit specific RNA in wild type and mutant S49 cells.

Albert DA, Nodzenski E, Yim G.

Adv Exp Med Biol. 1989;253B:93-7. No abstract available.

PMID:
2692434
20.

M2 subunit of ribonucleotide reductase is a target of cyclic AMP-dependent protein kinase.

Albert DA, Nodzenski E.

J Cell Physiol. 1989 Jan;138(1):129-36.

PMID:
2536034
21.

Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.

Albert DA, Nodzenski E.

Exp Cell Res. 1988 Dec;179(2):417-28.

PMID:
3056732
22.

Deoxyribonucleotide metabolism and cyclic AMP resistance in hydroxyurea-resistant S49 T-lymphoma cells.

Albert DA, Gudas LJ, Nodzenski E.

J Cell Physiol. 1987 Feb;130(2):262-9.

PMID:
3029148

Supplemental Content

Loading ...
Support Center